Valuation: Danaher Corporation

Market Cap 159B 140B 133B 120B 226B 15,231B 229B 1,589B 612B 7,788B 597B 584B 25,007B P/E 2026 *
37.5x
P/E 2027 * 30.6x
Enterprise Value 180B 158B 150B 135B 255B 17,205B 259B 1,794B 691B 8,797B 674B 659B 28,248B EV / Sales 2026 *
6.82x
EV / Sales 2027 * 6.15x
Free-Float
70.45%
Yield 2026 *
0.64%
Yield 2027 * 0.7%
1 day-1.84%
1 week+0.21%
Current month+3.74%
1 month+2.54%
3 months+14.92%
6 months+22.05%
Current year-3.22%
1 week 219
Extreme 219
228.38
1 month 199.09
Extreme 199.09
228.38
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
331.68
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer 62 2020-08-31
Director of Finance/CFO - 2026-02-27
Chief Tech/Sci/R&D Officer - 2025-08-24
Director TitleAgeSince
Director/Board Member 74 1999-06-30
Chairman 74 1983-12-31
Director/Board Member 69 1983-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/21/26 Sell

Chief Executive Officer

-58,255 0.0083%
8/4/26 Free

Chief Technology Officer

13,477 0.0019%
8/4/26 Free

Executive/Senior Manager

245,701 0.0350%
Change 5-day change 1-year change 3-year change Capi.($)
-1.84%+0.21%+19.07%-10.70% 159B
-0.67%+2.51%+46.10%+33.36% 251B
-1.35%+1.13%-7.42%+39.12% 146B
-0.52%-2.83%-55.02%-17.33% 63.59B
-2.00%-2.77%+11.83%+24.60% 50.77B
-1.55%+3.02%+39.24%+54.10% 49.35B
-1.76%+1.44%-16.73%-20.90% 48.75B
+2.47%+9.41%-2.58%+40.30% 45.1B
-0.87%+3.21%+51.81%+60.24% 43.55B
+0.62%+10.60%+197.90%+99.36% 41.07B
Average -0.75%+3.59%+28.42%+30.22% 89.8B
Weighted average by Cap. -0.95%+3.37%+24.53%+25.28%

Financials

2026 *2027 *
Net sales 26.34B 23.25B 21.98B 19.86B 37.48B 2,524B 37.93B 263B 101B 1,290B 98.89B 96.74B 4,144B 28.46B 25.12B 23.75B 21.46B 40.5B 2,727B 40.98B 284B 110B 1,394B 107B 105B 4,478B
Net income 4.18B 3.69B 3.49B 3.15B 5.95B 401B 6.02B 41.78B 16.09B 205B 15.7B 15.35B 658B 5.14B 4.54B 4.29B 3.88B 7.31B 492B 7.4B 51.37B 19.78B 252B 19.3B 18.88B 809B
Net Debt 20.6B 18.18B 17.19B 15.53B 29.31B 1,974B 29.66B 206B 79.28B 1,009B 77.34B 75.66B 3,241B 16.19B 14.29B 13.51B 12.21B 23.04B 1,551B 23.31B 162B 62.31B 793B 60.78B 59.46B 2,547B
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
26-09-30 US$221.55 -2.02% 5,129,009
26-09-29 US$226.11 -0.54% 3,608,532
26-09-28 US$227.33 +1.27% 4,929,772
26-09-25 US$224.49 +0.32% 4,423,721
26-09-24 US$223.77 +1.00% 6,196,747
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
221.55USD
Average target price
232.45USD
Spread / Average Target
+4.92%

Quarterly revenue - Rate of surprise